CA2246227A1 - Composition for the transfection of higher eucaryotic cells - Google Patents

Composition for the transfection of higher eucaryotic cells Download PDF

Info

Publication number
CA2246227A1
CA2246227A1 CA002246227A CA2246227A CA2246227A1 CA 2246227 A1 CA2246227 A1 CA 2246227A1 CA 002246227 A CA002246227 A CA 002246227A CA 2246227 A CA2246227 A CA 2246227A CA 2246227 A1 CA2246227 A1 CA 2246227A1
Authority
CA
Canada
Prior art keywords
egla
composition according
peptide
transfection
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002246227A
Other languages
English (en)
French (fr)
Inventor
Ernst Wagner
Karl Mechtler
Antoine Kichler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2246227A1 publication Critical patent/CA2246227A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002246227A 1996-02-15 1997-02-13 Composition for the transfection of higher eucaryotic cells Abandoned CA2246227A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19605548A DE19605548A1 (de) 1996-02-15 1996-02-15 Zusammensetzung für die Transfektion höherer eukaryotischer Zellen
DE19605548.2 1996-02-15

Publications (1)

Publication Number Publication Date
CA2246227A1 true CA2246227A1 (en) 1997-08-21

Family

ID=7785445

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002246227A Abandoned CA2246227A1 (en) 1996-02-15 1997-02-13 Composition for the transfection of higher eucaryotic cells

Country Status (6)

Country Link
EP (1) EP0900281A1 (de)
JP (1) JP2000504579A (de)
CA (1) CA2246227A1 (de)
DE (1) DE19605548A1 (de)
MX (1) MX9805507A (de)
WO (1) WO1997030170A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766706B1 (fr) * 1997-07-30 2001-05-25 Biovector Therapeutics Sa Complexes particulaires stables de charge globale neutre ou negative de structure multilamellaire composes par au moins une substance biologiquement active globalement anionique et un constituant cationique, leur preparation et utilisation
FR2766705B1 (fr) * 1997-07-30 2001-05-25 Biovector Therapeutics Complexe particulaire de charge globale neutre ou negative forme d'une vesicule cationique ou neutre et d'une substance biologiquement active anionique, leur preparation et leur utilisation
GB9918670D0 (en) 1999-08-06 1999-10-13 Celltech Therapeutics Ltd Biological product
GB0120022D0 (en) * 2001-08-16 2001-10-10 Photobiotics Ltd Conjugate
HUE026646T2 (en) 2010-07-06 2016-07-28 Glaxosmithkline Biologicals Sa Preferred liposomes containing lipids of PKA value for delivery of RNA
PL2591114T3 (pl) 2010-07-06 2017-08-31 Glaxosmithkline Biologicals Sa Immunizacja dużych ssaków małymi dawkami rna
HUE047796T2 (hu) 2010-07-06 2020-05-28 Glaxosmithkline Biologicals Sa RNS bevitele több immunútvonal bekapcsolására
PT3970742T (pt) 2010-08-31 2022-06-27 Glaxosmithkline Biologicals Sa Lipossomas peguilados para entrega de arn codificador de imunogénio
JP2013544504A (ja) 2010-10-11 2013-12-19 ノバルティス アーゲー 抗原送達プラットフォーム
WO2013006838A1 (en) 2011-07-06 2013-01-10 Novartis Ag Immunogenic combination compositions and uses thereof
US20140141070A1 (en) 2011-07-06 2014-05-22 Andrew Geall Liposomes having useful n:p ratio for delivery of rna molecules
WO2013051718A1 (ja) 2011-10-07 2013-04-11 国立大学法人三重大学 キメラ抗原受容体
WO2017024318A1 (en) 2015-08-06 2017-02-09 Dana-Farber Cancer Institute, Inc. Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
US11052111B2 (en) 2015-12-08 2021-07-06 Chimera Bioengineering, Inc. Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses
EP4342978A3 (de) 2016-09-01 2024-07-03 Chimera Bioengineering Inc. Goldoptimierte car-t-zellen
EP3580212A4 (de) 2017-02-08 2021-03-17 Dana Farber Cancer Institute, Inc. Regulierung von chimären antigenrezeptoren
EP3790896A1 (de) 2018-05-07 2021-03-17 Children's Hospital Medical Center Chimere polypeptide, nukleinsäuremoleküle, zellen und verwandte verfahren
AU2020257748A1 (en) 2019-04-19 2021-11-18 Chugai Seiyaku Kabushiki Kaisha Chimeric receptor recognizing modification site of antibody
JPWO2020246563A1 (de) 2019-06-05 2020-12-10
CN116194124A (zh) 2020-07-31 2023-05-30 中外制药株式会社 包含表达嵌合受体的细胞的药物组合物
WO2022196719A1 (ja) 2021-03-17 2022-09-22 第一三共株式会社 抗アセチルコリン受容体自己抗体に対するキメラ受容体をコードする遺伝子
US20240366666A1 (en) 2021-04-08 2024-11-07 Phosphogam, Llc Methods and compositions for enhancing the cytotoxicity of gamma/delta-t cells
JPWO2024150525A1 (de) 2023-01-12 2024-07-18

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
WO1995002698A1 (en) * 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
FR2714830B1 (fr) * 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
US5928944A (en) * 1994-02-04 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method of adenoviral-medicated cell transfection
US5736392A (en) * 1995-06-07 1998-04-07 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
IL115199A (en) * 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Also Published As

Publication number Publication date
DE19605548A1 (de) 1997-09-04
JP2000504579A (ja) 2000-04-18
WO1997030170A1 (de) 1997-08-21
MX9805507A (es) 1998-11-29
EP0900281A1 (de) 1999-03-10

Similar Documents

Publication Publication Date Title
CA2246227A1 (en) Composition for the transfection of higher eucaryotic cells
AU747803B2 (en) Novel compositions for the delivery of negatively charged molecules
US8058068B2 (en) Peptide-enhanced transfections
US7772201B2 (en) Highly branched HK peptides as effective carriers of siRNA
Martin et al. Peptide-guided gene delivery
JP4265699B2 (ja) ペプチドによって増強されるトランスフェクション
ES2200051T3 (es) Metodos y composiciones para la lipidizacion de moleculas hidrofilas.
US7553830B2 (en) Compositions for the delivery of negatively charged molecules
SK281543B6 (sk) Farmaceutická kompozícia na transfekciu nukleovej kyseliny
US20030165567A1 (en) Histidine copolymer and methods for using same
JPH11506935A (ja) ペプチド増強カチオン脂質トランスフェクション
SK282173B6 (sk) Lipopolyamíny ako transfekčné činidlá, spôsob ich prípravy a farmaceutické kompozície s ich obsahom
RU2739987C2 (ru) Множественные олигонуклеотидные фрагменты на пептидном носителе
US9399016B2 (en) Materials and complexes for the delivery of biologically-active materials to cells
US6281371B1 (en) Lipopolyamines, and the preparation and use thereof
AU720697B2 (en) Pharmaceutical composition which is useful for the transfection of nucleic acids, and uses thereof
JP2019510083A (ja) 生物学的活性物質の細胞への送達のための脂質および複合体
WO1999065461A3 (en) Cationic amphiphile micellar complexes
US7297712B2 (en) Cationic amphiphiles for intracellular delivery of therapeutic molecules and its composition, process and method of treatment
WO2024110492A9 (en) Novel carriers for nucleic acid and/or protein delivery
CN120737148A (zh) 经由穿膜肽进行非共价修饰脂质纳米颗粒缀合物及用途
Chaum et al. LIPID MEDIATED GENE TRANSFER LIPID MEDIATED GENE TRANSFER
EP1724254A2 (de) Zubereitungen zur abgabe von negativ geladenen molekülen
MXPA97006016A (en) Composition containing nucleic acids, preparation and use
KR20180010235A (ko) 생물학적으로 절단가능한 테트라펩티드 연결제

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead